Navigation Links
Johnson & Johnson Completes Acquisition of Cougar Biotechnology
Date:7/10/2009

NEW BRUNSWICK, N.J., July 10 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) today announced it has successfully completed its acquisition of Cougar Biotechnology, Inc., a development stage biopharmaceutical company with a specific focus on oncology.

Johnson & Johnson's tender offer for shares of Cougar Biotechnology common stock expired at 5 p.m. Eastern Daylight Time (EDT) yesterday with approximately 20,148,930,000 shares tendered, representing approximately 95.9% of Cougar Biotechnology's outstanding common stock. The acquisition was completed yesterday through what is known as a "short-form" merger, without a vote or meeting of Cougar Biotechnology's remaining shareholders.

Cougar Biotechnology currently is conducting two Phase III trials for abiraterone acetate, a late stage, first-in-class compound for the treatment of prostate cancer. The first Phase III trial is testing abiraterone acetate in patients with metastatic, castration-resistant prostate cancer who have progressed after docetaxel-based chemotherapy has failed. The second Phase III trial is studying abiraterone acetate in patients with metastatic, castration-resistant prostate cancer who have yet to receive chemotherapy.

One in six men will be diagnosed with prostate cancer in his lifetime, and the disease accounts for 10 percent of cancer-related deaths in the United States.

Cougar Biotechnology now operates as a wholly-owned subsidiary of Johnson & Johnson and will work with Ortho Biotech Oncology Research & Development, a unit of Centocor Research & Development, Inc., a Johnson & Johnson company.

"With the acquisition of Cougar Biotechnology and its talented team, we have strengthened our position in the global oncology market and our efforts to provide
'/>"/>

SOURCE Johnson & Johnson
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
2. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
3. Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
4. Entry of Biogenerics and Decreasing Use of Amgens Epogen and Johnson & Johnsons Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
5. Johnson & Johnson Announces Changes to Accelerate Growth
6. Drugs from Johnson & Johnson/Basilea and Forest Are the Most Promising Antibiotics in the Community-Acquired Pneumonia Pipeline
7. Two-time Defending NASCAR Sprint Cup Series Champion Jimmie Johnson Joins the Team at CORD:USE Cord Blood Bank to Help Win the Race for Life
8. MultiVu Video Feed: Johnson & Johnson Diabetes Institute, LLC Launches New Training Center to Improve Community-Based Diabetes Care
9. Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets
10. Craig Johnson Joins Ardea Biosciences Board of Directors
11. Migenix averts proxy contest; reaches agreement with DJohnson holdings

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...wswire/ -- Reportlinker.com announces that a new m...e: ,, Carbondioxide Incubators - A Global Mark.../p0164368/Carbondioxide-Incubators---A-Global-Mark...t critical equipment used in microbiology, genetic...oviding a controlled environment to grow and store...
(Date:12/2/2009)...swire-FirstCall/ - Oncolytics Biotech Inc. ("Oncol...announced today that in connection with its previo...e exercised in full their over-allotment option an... is comprised of one common share and 0.4 of a com...e of US$3.00 per unit. Each whole common share pur...
(Date:12/2/2009)...wswire/ -- S*BIO Pte Ltd today announced data pres..., at The American Society of Hematology 51st Annua...a will be presented on the clinical results from t...ng its safety, tolerability and pharmacokinetic/ph...ng from 100 to 600 mg. These doses were administer...
(Date:12/2/2009)...a leading scientific magazine covering the life sc...ntelligent” EMCCD camera fourth among the pu...9. , (PRWEB) December 2, ...otometrics ®, a designer and manufacturer of h... sciences, was ranked fourth among The Scientist&r...
Breaking Biology Technology:Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3
...maceuticals,Inc. (Nasdaq: CADX ), a biopharmaceut...d commercializing proprietary product candidates p...ced today that the company,s,President and CEO The...w on,Thursday, September 27, 2007 at 11:30 am East...7 Global Life Sciences Conference in New York City...
...Pharmaceuticals, Inc. (Nasdaq: ISIS ) announced t...ences, Inc. (Ibis), has been awarded four new,gove...vance the detection,and identification of microbia... of these contracts are from the Department of Hom...(DHS-S&T) and total up to approximately,$3.3 milli...
... EpiStem,(LSE: EHP) announced today that it has c...ing services for potential biodefense drugs, and a...g programme over the coming,year. The National In...gainst,Radiological and Nuclear Threats (MCART) pr...s for radiation sickness following a nuclear terro...
Other Biology Technology:Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at UBS 2007 Global Life Sciences Conference 2Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development 2Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development 3Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development 4EpiStem Successfully Complete First Year of Mucositis Tests for NIH Biodefence Programme 2EpiStem Successfully Complete First Year of Mucositis Tests for NIH Biodefence Programme 3
(Date:12/2/2009)...ke for a prolonged period of time and in high quan...in women who never smoked cigarettes themselves. ...am smoke could increase risk of breast cancer is o..., senior research scientist at the Northern Califo...ngle epidemiologic study can answer the question, ...
(Date:12/2/2009)...n forest,s woodland herb population has shown that...s recover from logging, according to Purdue Univer...ns of the forest nearly 80 years ago, the distribu...oor was similar to that of undisturbed areas. Mich...try and natural resources, said that contrasts wit...
(Date:12/2/2009)... College of Veterinary Medicine have made an "unex... for treating Ichthyophthirius multifiliis, or "Ic... that commonly attacks freshwater fish. , With t...nd that Ich harbors two apparently symbiotic intra... found free-living, and Rickettsia, which are obli...
Breaking Biology News(10 mins):Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2Study finds logging effects vary based on a forest's history, climate 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 3Proteolix Inc to be Acquired By Onyx Pharmaceuticals 59278 1Proteolix Inc to be Acquired By Onyx Pharmaceuticals 59278 2Proteolix Inc to be Acquired By Onyx Pharmaceuticals 59278 3Proteolix Inc to be Acquired By Onyx Pharmaceuticals 59278 4Frost 26amp 3B Sullivans 2009 Excellence in Healthcare Awards Banquet Honours Industrys Top Performers 14430 1Frost 26amp 3B Sullivans 2009 Excellence in Healthcare Awards Banquet Honours Industrys Top Performers 14430 2Frost 26amp 3B Sullivans 2009 Excellence in Healthcare Awards Banquet Honours Industrys Top Performers 14430 3Elbit Imaging Ltd Announces Sale of Plaza Centers Shares 5375 1Elbit Imaging Ltd Announces Sale of Plaza Centers Shares 5375 2Elbit Imaging Ltd Announces Sale of Plaza Centers Shares 5375 3
...still a major killer, especially in the western wo...er techniques could now be imminent. Progress is b...ew therapies on human heart tissue, with animal mo...ces in structure and activity. The only solution i...mputerised in-silico models that simulate the real...
...gging some 60,000 kilometers across ocean floors, ...role in many workings of the planet, from its plat...r, and the chemistry of rock, water and air. It wa...red the existence of vast plumbing systems under t... then spit it back out from seafloor ventsa proces...
...ethadone is a possible cause of sudden cardiac dea...rapeutic levels primarily for relief of chronic pa...egon Health & Science University researchers sugge...ary 2008 issue of The American Journal of Medicine... deaths in the greater Portland, Ore., metropolita...
Other Biology News:The construction of heart modelling leads path to new therapies 2The construction of heart modelling leads path to new therapies 3Quakes under Pacific floor reveal unexpected circulatory system 2Quakes under Pacific floor reveal unexpected circulatory system 3Methadone even at therapeutic levels can kill 2Methadone even at therapeutic levels can kill 3
384 Well PCR Plate Carrier for Thermo-Sealer from ABgene
Corning brand cover glass squares, 0.16 to 0.19mm thick from Sigma-Aldrich
...er slips for in situ hybridization,in situPCR, and... Constant probe concentration-Unlike glass cover ...o-use-Hybri-slips do not require pre-treatment pri... supplied RNAse-free and are protected from contam...
P/ACE™ MDQ Molecular Characterization System from Beckman Coulter
Biology Products: